Von dem Buch Anticancer Therapeutics (Hardcover) haben wir 2 gleiche oder sehr ähnliche Ausgaben identifiziert!
Falls Sie nur an einem bestimmten Exempar interessiert sind, können Sie aus der folgenden Liste jenes wählen, an dem Sie interessiert sind:
100%: Sotiris Missailidis (The Open University): Anticancer Therapeutics (Hardcover) (ISBN: 9780470723036) 2008, Erstausgabe, in Englisch, Broschiert.Nur diese Ausgabe anzeigen…
100%: Sotiris Missailidis: Anticancer Therapeutics (ISBN: 9780470697030) 2008, in Englisch, auch als eBook.Nur diese Ausgabe anzeigen…
Anticancer Therapeutics (Hardcover) - 8 Angebote vergleichen
| Preise | 2011 | 2013 | 2014 | 2015 |
|---|---|---|---|---|
| Schnitt | € 112,08 | € 106,53 | € 112,91 | € 107,52 |
| Nachfrage |
1
Anticancer Therapeutics
EN HC NW FEISBN: 9780470723036 bzw. 0470723033, in Englisch, Wiley & Sons, gebundenes Buch, neu, Erstausgabe.
Lieferung aus: Deutschland, Versandkostenfrei.
buecher.de GmbH & Co. KG, [1].
The need to re-address known anti-cancer agents and discover new ones are of paramount importance. Anticancer Therapeutics provides a comprehensive overview of the wealth of information currently available on this important and fast-moving subject. The book provides a clear introduction to the area, with a historical overview of initial developments of cancer therapeutics and their progress in today's multidisciplinary approach to cancer treatment. Coverage includes currently used mainline molecular treatment approaches as well as "the drugs of tomorrow," making this an invaluable resource for postgraduates and researchers.1. Auflage. 2008. 544 p. 244 mmVersandfertig in über 4 Wochen, Hardcover.
buecher.de GmbH & Co. KG, [1].
The need to re-address known anti-cancer agents and discover new ones are of paramount importance. Anticancer Therapeutics provides a comprehensive overview of the wealth of information currently available on this important and fast-moving subject. The book provides a clear introduction to the area, with a historical overview of initial developments of cancer therapeutics and their progress in today's multidisciplinary approach to cancer treatment. Coverage includes currently used mainline molecular treatment approaches as well as "the drugs of tomorrow," making this an invaluable resource for postgraduates and researchers.1. Auflage. 2008. 544 p. 244 mmVersandfertig in über 4 Wochen, Hardcover.
2
Anticancer Therapeutics (2008)
~EN NW EB DLISBN: 9780470697030 bzw. 0470697032, vermutlich in Englisch, John Wiley & Sons, neu, E-Book, elektronischer Download.
Lieferung aus: Deutschland, Free shipping.
Anticancer Therapeutics: Written by the winner of the 2008 Mike Price Fellowship" This volume provides a comprehensive overview of the wealth of information now available in this important and fast-moving subject." Anticancer Research, November - December 2008This book provides a clear introduction to the area, with an overview of the various drug design and development approaches for cancer therapeutics and their progress in today’ s multidisciplinary approach to cancer treatment.Clearly structured throughout, the book not only provides information on currently used molecular treatment approaches, but also describes the various agents that are currently at various stages of development and clinical trials, thus making them the drugs of tomorrow.The book goes on to present current therapeutic regimes including their indications and side effects, as well as their position in the international market in terms of sales and development costs. Furthermore, coverage of our advancement in the understanding of cancer biology and how this has driven the drug discovery process is clearly discussed. Modern drug discovery aspects, through genomic, proteomic and metabolomic approaches are referred to as well as combinatorial chemistry techniques and discovery of chemotherapeutic agents from plant extracts, re-use of old drugs and drugs from other indications, or de novo rational drug design.Including contributions from leading experts in the field, this book provides the reader with a complete overview of the various types of therapeutic agents, current and emerging, as well as other aspects associated with anticancer therapy, drug design, resistance and clinical trials in oncology. Englisch, Ebook.
Anticancer Therapeutics: Written by the winner of the 2008 Mike Price Fellowship" This volume provides a comprehensive overview of the wealth of information now available in this important and fast-moving subject." Anticancer Research, November - December 2008This book provides a clear introduction to the area, with an overview of the various drug design and development approaches for cancer therapeutics and their progress in today’ s multidisciplinary approach to cancer treatment.Clearly structured throughout, the book not only provides information on currently used molecular treatment approaches, but also describes the various agents that are currently at various stages of development and clinical trials, thus making them the drugs of tomorrow.The book goes on to present current therapeutic regimes including their indications and side effects, as well as their position in the international market in terms of sales and development costs. Furthermore, coverage of our advancement in the understanding of cancer biology and how this has driven the drug discovery process is clearly discussed. Modern drug discovery aspects, through genomic, proteomic and metabolomic approaches are referred to as well as combinatorial chemistry techniques and discovery of chemotherapeutic agents from plant extracts, re-use of old drugs and drugs from other indications, or de novo rational drug design.Including contributions from leading experts in the field, this book provides the reader with a complete overview of the various types of therapeutic agents, current and emerging, as well as other aspects associated with anticancer therapy, drug design, resistance and clinical trials in oncology. Englisch, Ebook.
3
Anticancer Therapeutics (2008)
EN NWISBN: 9780470723036 bzw. 0470723033, in Englisch, Wiley John & Sons Nov 2008, neu.
Von Händler/Antiquariat, Agrios-Buch [57449362], Bergisch Gladbach, NRW, Germany.
Neuware - Krebs steht bei den Todesursachen weltweit an zweiter Stelle. Die Forschung konzentriert sich zunehmend darauf, die Entstehung von Krebs ganzheitlich zu betrachten, bekannte Krebsmedikamente auf den Prüfstand zu stellen und Medikamente und kombinierte Therapieansätze zu entwickeln.Anticancer Therapeutics provides a comprehensive overview of the wealth of information now available in this important and fast-moving subject. The book provides a clear introduction to the area, with a historical overview of initial developments of cancer therapeutics and their progress in today's multidisciplinary approach to cancer treatment. The book not only provides information on the currently used mainline molecular treatment approaches, but also describes the various agents that are currently at various stages of development and clinical trials, thus making them the drugs of tomorrow.The book thoroughly describes the current therapeutic regimes, with their indications and side effects, as well as their position in the international market interms of sales and development costs. Furthermore, the book includes a discussion of our advancement in the understanding of cancer biology and how this has driven the drug discovery process. Modern drug discovery aspects, through genomic, proteomic and metabolomic approaches are referred to as well as combinatorial chemistry techniques and discovery of chemotherapeutic agents from plant extracts, re-use of old drugs and drugs from other indications, or de novo rational drug design. These have lead to the basic areas of drug development, such as chemotherapy, immunotherapy, radiotherapy, gene therapy, cancer vaccines and potential experimental therapies that may influence the cancer scene in the next 10-20 years, including aptamers, antisense and antigene, siRNA etc.Anticancer Therapeutics provides an opportunity to compare such novel therapies with small molecules and biologics, such as Gleevec and Herceptin. Finally, other crucial aspects in current and emerging anticancer therapeutics, such as development of resistance to chemotherapy, including the various processes that drive it, and the pharmacological aspects of cancer therapy will be discussed.There are currently no books on the market that cover this broad area of anticancer therapeutics in its entirety and in particular, the emerging modalities that will influence the treatment of cancer in the years to come. Including contributions from leading experts in the field, this book will provide the reader with a complete overview of the various types of therapeutic agents, current and emerging, as well as other aspects associated with anticancer therapy, drug design, resistance and pharmacology. 424 pp. Englisch.
Neuware - Krebs steht bei den Todesursachen weltweit an zweiter Stelle. Die Forschung konzentriert sich zunehmend darauf, die Entstehung von Krebs ganzheitlich zu betrachten, bekannte Krebsmedikamente auf den Prüfstand zu stellen und Medikamente und kombinierte Therapieansätze zu entwickeln.Anticancer Therapeutics provides a comprehensive overview of the wealth of information now available in this important and fast-moving subject. The book provides a clear introduction to the area, with a historical overview of initial developments of cancer therapeutics and their progress in today's multidisciplinary approach to cancer treatment. The book not only provides information on the currently used mainline molecular treatment approaches, but also describes the various agents that are currently at various stages of development and clinical trials, thus making them the drugs of tomorrow.The book thoroughly describes the current therapeutic regimes, with their indications and side effects, as well as their position in the international market interms of sales and development costs. Furthermore, the book includes a discussion of our advancement in the understanding of cancer biology and how this has driven the drug discovery process. Modern drug discovery aspects, through genomic, proteomic and metabolomic approaches are referred to as well as combinatorial chemistry techniques and discovery of chemotherapeutic agents from plant extracts, re-use of old drugs and drugs from other indications, or de novo rational drug design. These have lead to the basic areas of drug development, such as chemotherapy, immunotherapy, radiotherapy, gene therapy, cancer vaccines and potential experimental therapies that may influence the cancer scene in the next 10-20 years, including aptamers, antisense and antigene, siRNA etc.Anticancer Therapeutics provides an opportunity to compare such novel therapies with small molecules and biologics, such as Gleevec and Herceptin. Finally, other crucial aspects in current and emerging anticancer therapeutics, such as development of resistance to chemotherapy, including the various processes that drive it, and the pharmacological aspects of cancer therapy will be discussed.There are currently no books on the market that cover this broad area of anticancer therapeutics in its entirety and in particular, the emerging modalities that will influence the treatment of cancer in the years to come. Including contributions from leading experts in the field, this book will provide the reader with a complete overview of the various types of therapeutic agents, current and emerging, as well as other aspects associated with anticancer therapy, drug design, resistance and pharmacology. 424 pp. Englisch.
4
Anticancer Therapeutics (2008)
EN NW EB DLISBN: 9780470697030 bzw. 0470697032, in Englisch, Wiley, neu, E-Book, elektronischer Download.
Lieferung aus: Vereinigtes Königreich Großbritannien und Nordirland, Despatched same working day before 3pm.
Written by the winner of the 2008 Mike Price Fellowship"This volume provides a comprehensive overview of the wealth of information now available in this important and fast-moving subject." Anticancer Research, November - December 2008This book provides a clear introduction to the area, with an overview of the various drug design and development approaches for cancer therapeutics and their progress in today s multidisciplinary approach to cancer treatment.Clearly structured throughout, the book not only provides information on currently used molecular treatment approaches, but also describes the various agents that are currently at various stages of development and clinical trials, thus making them the drugs of tomorrow.The book goes on to present current therapeutic regimes including their indications and side effects, as well as their position in the international market in terms of sales and development costs. Furthermore, coverage of our advancement in the understanding of cancer biology and how this has driven the drug discovery process is clearly discussed. Modern drug discovery aspects, through genomic, proteomic and metabolomic approaches are referred to as well as combinatorial chemistry techniques and discovery of chemotherapeutic agents from plant extracts, re-use of old drugs and drugs from other indications, or de novo rational drug design.Including contributions from leading experts in the field, this book provides the reader with a complete overview of the various types of therapeutic agents, current and emerging, as well as other aspects associated with anticancer therapy, drug design, resistance and clinical trials in oncology.
Written by the winner of the 2008 Mike Price Fellowship"This volume provides a comprehensive overview of the wealth of information now available in this important and fast-moving subject." Anticancer Research, November - December 2008This book provides a clear introduction to the area, with an overview of the various drug design and development approaches for cancer therapeutics and their progress in today s multidisciplinary approach to cancer treatment.Clearly structured throughout, the book not only provides information on currently used molecular treatment approaches, but also describes the various agents that are currently at various stages of development and clinical trials, thus making them the drugs of tomorrow.The book goes on to present current therapeutic regimes including their indications and side effects, as well as their position in the international market in terms of sales and development costs. Furthermore, coverage of our advancement in the understanding of cancer biology and how this has driven the drug discovery process is clearly discussed. Modern drug discovery aspects, through genomic, proteomic and metabolomic approaches are referred to as well as combinatorial chemistry techniques and discovery of chemotherapeutic agents from plant extracts, re-use of old drugs and drugs from other indications, or de novo rational drug design.Including contributions from leading experts in the field, this book provides the reader with a complete overview of the various types of therapeutic agents, current and emerging, as well as other aspects associated with anticancer therapy, drug design, resistance and clinical trials in oncology.
6
Anticancer Therapeutics
EN NWISBN: 9780470723036 bzw. 0470723033, in Englisch, Wiley John + Sons, neu.
bücher-galerie-ac, [3467807].
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Lade…